Traumatic Brain Injury (TBI) – Medical Marijuana

Endocannabinoids and traumatic brain injury

By admin| 2016-07-11T12:09:49+01:00 July 11th, 2016|

The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines

By admin| 2016-07-11T12:08:50+01:00 July 11th, 2016|

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist

By admin| 2016-07-11T12:08:14+01:00 July 11th, 2016|

Estradiol Decreases Cortical Reactive Astrogliosis after Brain Injury by a Mechanism Involving Cannabinoid Receptors

By admin| 2016-07-11T12:07:23+01:00 July 11th, 2016|

Endocannabinoids and traumatic brain injury

By admin| 2016-07-11T10:46:20+01:00 July 11th, 2016|

Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet

By admin| 2016-07-11T10:45:36+01:00 July 11th, 2016|

CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice

By admin| 2016-07-11T10:44:46+01:00 July 11th, 2016|

Cannabinoid agonist rescues learning and memory after a traumatic brain injury

By admin| 2016-07-11T10:43:52+01:00 July 11th, 2016|

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

By admin| 2016-07-11T09:47:07+01:00 July 11th, 2016|